Magenta Therapeutics
Why Robinhood?
You can watch MGTA and buy or sell other stocks, ETFs, and their options commission-free!About MGTA
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies.
MGTA Key Statistics
Stock Snapshot
As of today, Magenta Therapeutics(MGTA) shares are valued at $11.99. The company's market cap stands at 518.24M, with a P/E ratio of -20.91.
On 2026-04-05, Magenta Therapeutics(MGTA) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 1.38M.
Over the past 52 weeks, Magenta Therapeutics(MGTA) stock has traded between a high of $88.49 and a low of $13.37.
Over the past 52 weeks, Magenta Therapeutics(MGTA) stock has traded between a high of $88.49 and a low of $13.37.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.